世界のヌクレオチド・サプリメント市場予測（～2028年）：ピリミジン、プリン

• 英文タイトル：Global Nucleotides Supplements Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8908 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ヌクレオチド・サプリメント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のヌクレオチド・サプリメントの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ヌクレオチド・サプリメント市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ピリミジン、プリン 用途別セグメントは次のように区分されます。 ・病院、クリニック 世界のヌクレオチド・サプリメント市場の主要な市場プレーヤーは以下のとおりです。 ・ADM、BASF、Cargill、Adisseo、Ajinomoto Health & Nutrition、Leiber GmbH、Chr. Hansen Holding A/S、Lonza、Elanco、Kemin Industries、MeiHua Holdings Group、Biorigin、Promega Corporation、Agilent Technologies、Lallemand 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヌクレオチド・サプリメント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヌクレオチド・サプリメントメーカーの企業概要、2019年～2022年までのヌクレオチド・サプリメントの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヌクレオチド・サプリメントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ヌクレオチド・サプリメントの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのヌクレオチド・サプリメントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヌクレオチド・サプリメント市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびヌクレオチド・サプリメントの産業チェーンを掲載しています。 ・第13、14、15章では、ヌクレオチド・サプリメントの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ADM、BASF、Cargill、Adisseo、Ajinomoto Health & Nutrition、Leiber GmbH、Chr. Hansen Holding A/S、Lonza、Elanco、Kemin Industries、MeiHua Holdings Group、Biorigin、Promega Corporation、Agilent Technologies、Lallemand ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ピリミジン、プリン ・用途別分析2017年-2028年：病院、クリニック ・ヌクレオチド・サプリメントの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ヌクレオチド・サプリメントのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヌクレオチド・サプリメントのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヌクレオチド・サプリメントの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ヌクレオチド・サプリメントの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Nucleotides Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nucleotides Supplements market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Nucleotides Supplements global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pyrimidine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nucleotides Supplements include ADM, BASF, Cargill, Adisseo, and Ajinomoto Health & Nutrition, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nucleotides Supplements market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pyrimidine
Purine
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Nucleotides Supplements market are listed below:
ADM
BASF
Cargill
Adisseo
Ajinomoto Health & Nutrition
Leiber GmbH
Chr. Hansen Holding A/S
Lonza
Elanco
Kemin Industries
MeiHua Holdings Group
Biorigin
Promega Corporation
Agilent Technologies
Lallemand
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nucleotides Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nucleotides Supplements, with price, sales, revenue and global market share of Nucleotides Supplements from 2019 to 2022.
Chapter 3, the Nucleotides Supplements competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nucleotides Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nucleotides Supplements market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleotides Supplements.
Chapter 13, 14, and 15, to describe Nucleotides Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Nucleotides Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nucleotides Supplements Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pyrimidine
1.2.3 Purine
1.3 Market Analysis by Application
1.3.1 Overview: Global Nucleotides Supplements Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Nucleotides Supplements Market Size & Forecast
1.4.1 Global Nucleotides Supplements Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nucleotides Supplements Sales in Volume (2017-2028)
1.4.3 Global Nucleotides Supplements Price (2017-2028)
1.5 Global Nucleotides Supplements Production Capacity Analysis
1.5.1 Global Nucleotides Supplements Total Production Capacity (2017-2028)
1.5.2 Global Nucleotides Supplements Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nucleotides Supplements Market Drivers
1.6.2 Nucleotides Supplements Market Restraints
1.6.3 Nucleotides Supplements Trends Analysis
2 Manufacturers Profiles
2.1 ADM
2.1.1 ADM Details
2.1.2 ADM Major Business
2.1.3 ADM Nucleotides Supplements Product and Services
2.1.4 ADM Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Nucleotides Supplements Product and Services
2.2.4 BASF Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cargill
2.3.1 Cargill Details
2.3.2 Cargill Major Business
2.3.3 Cargill Nucleotides Supplements Product and Services
2.3.4 Cargill Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Adisseo
2.4.1 Adisseo Details
2.4.2 Adisseo Major Business
2.4.3 Adisseo Nucleotides Supplements Product and Services
2.4.4 Adisseo Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ajinomoto Health & Nutrition
2.5.1 Ajinomoto Health & Nutrition Details
2.5.2 Ajinomoto Health & Nutrition Major Business
2.5.3 Ajinomoto Health & Nutrition Nucleotides Supplements Product and Services
2.5.4 Ajinomoto Health & Nutrition Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Leiber GmbH
2.6.1 Leiber GmbH Details
2.6.2 Leiber GmbH Major Business
2.6.3 Leiber GmbH Nucleotides Supplements Product and Services
2.6.4 Leiber GmbH Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chr. Hansen Holding A/S
2.7.1 Chr. Hansen Holding A/S Details
2.7.2 Chr. Hansen Holding A/S Major Business
2.7.3 Chr. Hansen Holding A/S Nucleotides Supplements Product and Services
2.7.4 Chr. Hansen Holding A/S Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business
2.8.3 Lonza Nucleotides Supplements Product and Services
2.8.4 Lonza Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Elanco
2.9.1 Elanco Details
2.9.2 Elanco Major Business
2.9.3 Elanco Nucleotides Supplements Product and Services
2.9.4 Elanco Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Kemin Industries
2.10.1 Kemin Industries Details
2.10.2 Kemin Industries Major Business
2.10.3 Kemin Industries Nucleotides Supplements Product and Services
2.10.4 Kemin Industries Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MeiHua Holdings Group
2.11.1 MeiHua Holdings Group Details
2.11.2 MeiHua Holdings Group Major Business
2.11.3 MeiHua Holdings Group Nucleotides Supplements Product and Services
2.11.4 MeiHua Holdings Group Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Biorigin
2.12.1 Biorigin Details
2.12.2 Biorigin Major Business
2.12.3 Biorigin Nucleotides Supplements Product and Services
2.12.4 Biorigin Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Promega Corporation
2.13.1 Promega Corporation Details
2.13.2 Promega Corporation Major Business
2.13.3 Promega Corporation Nucleotides Supplements Product and Services
2.13.4 Promega Corporation Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Agilent Technologies
2.14.1 Agilent Technologies Details
2.14.2 Agilent Technologies Major Business
2.14.3 Agilent Technologies Nucleotides Supplements Product and Services
2.14.4 Agilent Technologies Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Lallemand
2.15.1 Lallemand Details
2.15.2 Lallemand Major Business
2.15.3 Lallemand Nucleotides Supplements Product and Services
2.15.4 Lallemand Nucleotides Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nucleotides Supplements Breakdown Data by Manufacturer
3.1 Global Nucleotides Supplements Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nucleotides Supplements Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nucleotides Supplements
3.4 Market Concentration Rate
3.4.1 Top 3 Nucleotides Supplements Manufacturer Market Share in 2021
3.4.2 Top 6 Nucleotides Supplements Manufacturer Market Share in 2021
3.5 Global Nucleotides Supplements Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nucleotides Supplements Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nucleotides Supplements Market Size by Region
4.1.1 Global Nucleotides Supplements Sales in Volume by Region (2017-2028)
4.1.2 Global Nucleotides Supplements Revenue by Region (2017-2028)
4.2 North America Nucleotides Supplements Revenue (2017-2028)
4.3 Europe Nucleotides Supplements Revenue (2017-2028)
4.4 Asia-Pacific Nucleotides Supplements Revenue (2017-2028)
4.5 South America Nucleotides Supplements Revenue (2017-2028)
4.6 Middle East and Africa Nucleotides Supplements Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nucleotides Supplements Sales in Volume by Type (2017-2028)
5.2 Global Nucleotides Supplements Revenue by Type (2017-2028)
5.3 Global Nucleotides Supplements Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nucleotides Supplements Sales in Volume by Application (2017-2028)
6.2 Global Nucleotides Supplements Revenue by Application (2017-2028)
6.3 Global Nucleotides Supplements Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nucleotides Supplements Sales by Type (2017-2028)
7.2 North America Nucleotides Supplements Sales by Application (2017-2028)
7.3 North America Nucleotides Supplements Market Size by Country
7.3.1 North America Nucleotides Supplements Sales in Volume by Country (2017-2028)
7.3.2 North America Nucleotides Supplements Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nucleotides Supplements Sales by Type (2017-2028)
8.2 Europe Nucleotides Supplements Sales by Application (2017-2028)
8.3 Europe Nucleotides Supplements Market Size by Country
8.3.1 Europe Nucleotides Supplements Sales in Volume by Country (2017-2028)
8.3.2 Europe Nucleotides Supplements Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nucleotides Supplements Sales by Type (2017-2028)
9.2 Asia-Pacific Nucleotides Supplements Sales by Application (2017-2028)
9.3 Asia-Pacific Nucleotides Supplements Market Size by Region
9.3.1 Asia-Pacific Nucleotides Supplements Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nucleotides Supplements Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nucleotides Supplements Sales by Type (2017-2028)
10.2 South America Nucleotides Supplements Sales by Application (2017-2028)
10.3 South America Nucleotides Supplements Market Size by Country
10.3.1 South America Nucleotides Supplements Sales in Volume by Country (2017-2028)
10.3.2 South America Nucleotides Supplements Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nucleotides Supplements Sales by Type (2017-2028)
11.2 Middle East & Africa Nucleotides Supplements Sales by Application (2017-2028)
11.3 Middle East & Africa Nucleotides Supplements Market Size by Country
11.3.1 Middle East & Africa Nucleotides Supplements Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nucleotides Supplements Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nucleotides Supplements and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nucleotides Supplements
12.3 Nucleotides Supplements Production Process
12.4 Nucleotides Supplements Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nucleotides Supplements Typical Distributors
13.3 Nucleotides Supplements Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---